Portfolio company
Arboretum
United States · £23.7m raised
Raised
£23.7m
Latest stage
Series A
Rounds recorded
1
Backed by
2 investors
Sectors
About
The company provides genetic testing and molecular data platforms to healthcare systems and biopharmaceutical developers for common disease research and precision medicine.
SourceFunding history · 1
Similar companies
Arboretum LifeSciences, Inc.
This molecular information company develops genetic testing and AI-driven data platforms for biopharmaceutical firms and healthcare providers to enable precision medicine for common diseases.
TMA Precision Health
This company provides a clinical decision support platform using genomic data and medical records to improve rare disease diagnosis for health systems and pharmaceutical partners.
Healthcare insights platform
This company provides a data analytics platform that integrates genetic information and clinical research to assist pharmaceutical firms in developing precision medicine and treatments.
Arbor Biotechnologies
This company develops programmable gene-editing tools and genetic medicines to treat patients with liver and central nervous system diseases.
Sano Genetics
This company provides a software platform connecting patients with chronic conditions to pharmaceutical researchers for precision medicine clinical trials and genetic testing.
Adrestia
This company develops precision medicines for rare and common genetic diseases by using a molecular biology platform to identify and rescue cellular imbalances.
Fabric Genomics
This company provides a clinical software platform for genomic data interpretation and reporting to diagnostic laboratories and hospital systems.
Genomenon
This company develops genomic search engines and data platforms for pharmaceutical companies and clinical laboratories to assist in disease diagnosis and drug development.
